Skip to main content

Journal Club

Our global experts summarize key findings from the latest clinical trials in a half-hour weekly virtual presentation and panel discussion. Our insights help viewers integrate the latest information into their clinical practice in this constantly evolving field.

Filter

Primary Results from the TRISCEND II Pivotal Trial with Rebecca Hahn

Severe tricuspid regurgitation (TR) often causes substantial impairment in patient-reported health status (ie, symptoms, physical and social function, and quality of life), which may improve with transcatheter tricuspid valve replacement…
February 15, 2025

INFINITY-SWEDEHEART

February 1, 2025